A Phase 2b Study to Assess IMVT-1402 in Participants with Cutaneous Lupus Erythematosus
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Immunovant
Start Date
May 7, 2025
End Date
November 30, 2029
Administered By
Dermatology
Awarded By
Immunovant
Start Date
May 7, 2025
End Date
November 30, 2029